Upkar S. Gill

London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 77 publications

Preserved CD4 + T cell helper function and coordinated antiviral immunity in people with HBV/HIV co-infection on long-term therapy.

Preserved CD4 + T cell helper function and coordinated antiviral immunity in people with HBV/HIV co-infection on long-term therapy.

Journal: bioRxiv : the preprint server for biology

Published: June 12, 2026

From targets to real world impact: a review of models of care for chronic HBV and HCV in Europe.

From targets to real world impact: a review of models of care for chronic HBV and HCV in Europe.

Journal: The Lancet regional health. Europe

Published: December 02, 2025

Corrigendum to "Auto-antibodies against interferons are common in people living with chronic hepatitis B virus infection and associate with PegIFNα non-response" [J Hepatol (2025) 101382].

Corrigendum to "Auto-antibodies against interferons are common in people living with chronic hepatitis B virus infection and associate with PegIFNα non-response" [J Hepatol (2025) 101382].

Journal: JHEP reports : innovation in hepatology

Published: October 24, 2025

Introducing Gut Science-a fundamental and discovery science companion journal to Gut.

Introducing Gut Science-a fundamental and discovery science companion journal to Gut.

Journal: Gut

Published: September 30, 2025

Chronic hepatitis B in 2025: diagnosis, treatment and future directions.

Chronic hepatitis B in 2025: diagnosis, treatment and future directions.

Journal: Clinical medicine (London, England)

Published: August 15, 2025

Expanded adaptive NKG2C+ NK cells exhibit potent ADCC and functional responses against HBV-infected hepatoma cell lines.

Expanded adaptive NKG2C+ NK cells exhibit potent ADCC and functional responses against HBV-infected hepatoma cell lines.

Journal: bioRxiv : the preprint server for biology

Published: June 12, 2025

Expanded adaptive NKG2C+ NK cells exhibit potent ADCC and functional responses against HBV-infected hepatoma cell lines.

Expanded adaptive NKG2C+ NK cells exhibit potent ADCC and functional responses against HBV-infected hepatoma cell lines.

Journal: Cytotherapy

Published: June 04, 2025

Stem-like CD8+ T cells preserve HBV-specific responses in HBV/HIV co-infection.

Stem-like CD8+ T cells preserve HBV-specific responses in HBV/HIV co-infection.

Journal: medRxiv : the preprint server for health sciences

Published: April 16, 2025

Stem-like CD8+ T cells preserve HBV-specific responses in HBV/HIV co-infection.

Stem-like CD8+ T cells preserve HBV-specific responses in HBV/HIV co-infection.

Journal: Gut

Published: April 01, 2025

Fine needle aspirates characterise the hepatocellular carcinoma immune niche to predict immune checkpoint inhibitor outcomes.

Fine needle aspirates characterise the hepatocellular carcinoma immune niche to predict immune checkpoint inhibitor outcomes.

Journal: JHEP reports : innovation in hepatology

Published: February 27, 2025

Rapid whole-blood immune profiling reveals heterogeneous HBV-specific T cell response patterns independent of clinical disease phases.

Rapid whole-blood immune profiling reveals heterogeneous HBV-specific T cell response patterns independent of clinical disease phases.

Journal: Journal of hepatology

Published: February 21, 2025

HBV Biomarkers and Their Role in Guiding Treatment Decisions.

HBV Biomarkers and Their Role in Guiding Treatment Decisions.

Journal: Seminars in liver disease

Published: October 23, 2024

Showing 1-12 of 77

Last Updated: 09/26/2026